Day: July 3, 2020

Los Angeles, CA, July 03, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems (“UVS”) sectors, is pleased to announce that lead director Scott Larson will be the company’s interim President to fulfill leadership requirements in the short term effective immediately.Mr. Larson brings over 20 years of combined operational, corporate finance, technology development and entrepreneurial experience to the Board. Previously CEO of Kater, a Vancouver-based mobility as a service (MaaS) company building out an integrated intermodal transportation platform incorporating public transportation, buses, taxis and ride...

This Agreement will allow for immediate distribution of leronlimab to patients for the treatment of COVID-19 upon successful completion of CytoDyn’s ongoing clinical trials and FDA approvalVANCOUVER, Washington, July 03, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has signed an exclusive Distribution and Supply Agreement with American Regent, Inc. (“American Regent”) for the  distribution of leronlimab for the treatment of COVID-19 in the United States.Under the terms of the agreement, CytoDyn will supply leronlimab for the treatment of COVID-19 for distribution by American Regent and receive quarterly payments based on a profit-sharing...

TORONTO, July 03, 2020 (GLOBE NEWSWIRE) — Angus Ventures Inc. (TSX-V: GUS) (“Angus” or the “Company”) is pleased to announce a that it has closed its previously announced non-brokered flow-through private placement for a gross proceeds of $2,646,000 (the “Financing”). The Financing was comprised of 6,000,000 flow-through shares of the Company (“FT Shares”) at a price of C$0.441 per FT Share. Each FT Share consists of one common share in the capital of the Company (a “Common Share”) issued on a flow-through basis within the meaning of the Income Tax Act (Canada) (“Tax Act”). The gross proceeds will be used to fund exploration on Angus’ projects. Gross proceeds received by the Company from the sale of FT Shares will be used to incur Canadian Exploration Expenses that are ”flow-through” mining expenditures as such terms are...

VANCOUVER, British Columbia, July 03, 2020 (GLOBE NEWSWIRE) — Pressure Technologies plc (“Pressure Technologies“) announced today that, through a series of trades on July 2, 2020, it has disposed of ownership and control of 7,663,920 common shares (“Greenlane Shares“) in the capital of Greenlane Renewables Inc. (“Greenlane“) and 5,094,765 warrants to purchase Greenlane Shares (“Warrants“, and together with the Greenlane Shares, the “PT Securities“), upon exercise thereof, representing approximately 8.36% of the issued and outstanding Greenlane Shares on an undiluted basis and approximately 13.18% on a partially diluted basis (assuming the exercise of the Warrants only). The disposition was made following the execution a framework agreement dated as of July 2, 2020 with Greenlane,...

VANCOUVER, British Columbia, July 03, 2020 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSXV: KNT; OTCQB:  KNTNF) announces that, further to the updated resource estimate for the Kora deposit at the Company’s Kainantu Gold Mine in Papua New Guinea (see May 19, 2020 Press Release: K92 Mining Inc. Reports Significant Resource Increase at High-Grade Kora Deposit), in consideration of the potential delays in obtaining signatories and certificates resulting from the COVID-19 pandemic, the Company will be postponing the filing of the technical report that is required to be filed by July 3, 2020, pursuant to section 4.2(l)(j) (technical report filing) of National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”).

          Dr. Pourhassan and Mobeen Syed, M.D., M.S. will discuss the Company’s multi-pathway to exploring the many potential opportunities for leronlimab, including COVID-19VANCOUVER, Washington, July 03, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn will be interviewed on the DrBeen webcast hosted by Mobeen Syed, M.D., M.S. on Saturday, July 4, 2020 at 6:00 pm PT. The interview will be available simultaneously on two channels:YouTube – DrBeen Medical LecturesLink:  https://www.youtube.com/c/USMLEOnlineFacebook: DrBeen MedicalLink:  https://m.facebook.com/drbeenmedicalDate: ...

Menthol cigarettes represent US $80 billion out of the US $814 billion global tobacco market, and a 36% share of the U.S. tobacco market alone. With menthol cigarette bans passed in jurisdictions to include Brazil, Canada, and the European Union, the Company has identified unmet demand that could continue to persist as more jurisdictions follow suit. Taat Beyond Tobacco™ cigarettes are to be offered in a menthol variety, which can appeal to menthol cigarette smokers. With a near-term planned product launch on track for Q4 2020, TAAT LTD believes Taat Beyond Tobacco™ cigarettes are well-positioned to capitalize on current and emerging trends relating to menthol cigarettes.LAS VEGAS and VANCOUVER, British Columbia, July 03, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (FRANKFURT: 2TP2) (the “Company” or...

MercadoLibre, Inc.2.00% Convertible Senior Notes due 2028CUSIP [58733RAD4]BUENOS AIRES, Argentina, July 03, 2020 (GLOBE NEWSWIRE) — NOTICE IS HEREBY GIVEN, pursuant to Section 14.01(b)(iv) of the Indenture, dated as of August 24, 2018 (the “Indenture”), by and between MercadoLibre, Inc. (the “Company”) and Wilmington Trust, National Association, as trustee, that the above-referenced notes (the “Notes”) have become convertible in accordance with said section, and may be surrendered for conversion at the option of the Holder thereof, through September 30, 2020, as a result of the Last Reported Sale Price of the Company’s Common Stock being more than 130% of the Conversion Price in effect on each applicable Trading Day during at least 20 of the last 30 consecutive Trading Days of the calendar quarter ended June 30, 2020.Capitalized...

PRESS RELEASE                                                                                  Roissy, 3 July 2020The Air France group plans measures to adapt its workforce to the COVID-19 crisisAir France and HOP! today presented the staff representatives with their strategic orientations and the prospects for adapting the workforce following the COVID-19 crisis which has hit the Group hard.For three months, Air France’s activity and revenue fell by 95%, and at the height of the crisis, the airline was losing 15 million euros per day. Recovery looks set to be very slow due to the uncertainties regarding the health situation, the lifting of travel restrictions and changing commercial demand. In this way, even on the basis of ambitious recovery assumptions, Air France predicts that it will not see the same level of activity as in...

COMMUNIQUE DE PRESSE                                                                                                                                  Roissy, le 3 juillet 2020Le groupe Air France prévoit des mesures d’adaptation de ses effectifs face à la crise du COVID-19Air France et HOP! ont présenté ce jour à leurs représentants du personnel leurs orientations stratégiques et les perspectives d’adaptation des effectifs consécutives à la crise du COVID-19 qui frappe durement le groupe.Pendant trois mois, l’activité et le chiffre d’affaires d’Air France ont chuté de 95 %, et au plus fort de la crise, la compagnie a perdu 15 millions d’euros par jour. La reprise s’annonce très lente en raison des nombreuses incertitudes qui persistent sur la situation sanitaire, la levée des restrictions de voyage et l’évolution de la demande commerciale....